NCT04292509View on ClinicalTrials.gov

Risk for Ketonaemia in Type 1 Diabetes Pregnancies With Sensor-augmented Pump Therapy

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

June 15, 2020

Study Completion Date

July 15, 2020

Conditions
Pregnant Women With Type 1 Diabetes
Interventions
DEVICE

SAP with stop before low

cross-over comparison from stop on low to stop before low

DEVICE

SAP with stop on low

cross-over comparison from stop before low to stop on low

Trial Locations (1)

Unknown

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04292509 - Risk for Ketonaemia in Type 1 Diabetes Pregnancies With Sensor-augmented Pump Therapy | Biotech Hunter | Biotech Hunter